肠道微生态与肠易激综合征:基础与临床

被引:25
作者
王鹏
李延青
机构
[1] 山东大学齐鲁医院消化内科
关键词
肠道菌群; 肠易激综合征; 菌群-肠-脑轴; 有益菌种;
D O I
暂无
中图分类号
R574.4 [肠道功能紊乱];
学科分类号
100201 [内科学];
摘要
肠道微生态与功能性胃肠病(FGIDs)的关系已成为目前研究热点之一。最新罗马Ⅳ标准指出FGIDs不仅仅是胃肠道疾病,脑-肠互动障碍可能贯穿肠易激综合征(IBS)发病的始终。肠道微生态失衡被认为是导致脑-肠互动障碍的重要始动因素,参与构成菌群-肠-脑轴,成为新兴研究热点。尤其是在IBS的研究中,肠道微生态失衡已被证实与IBS免疫异常和临床症状相关;使用益生菌调节IBS肠道菌群取得良好成效,其他相关菌群干预策略也在不断探索中。
引用
收藏
页码:193 / 197
页数:5
相关论文
共 14 条
[1]
Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome [J].
Ford, Alexander C. ;
Harris, Lucinda A. ;
Lacy, Brian E. ;
Quigley, Eamonn M. M. ;
Moayyedi, Paul .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (10) :1044-1060
[2]
FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial [J].
McIntosh, Keith ;
Reed, David E. ;
Schneider, Theresa ;
Dang, Frances ;
Keshteli, Ammar H. ;
De Palma, Giada ;
Madsen, Karen ;
Bercik, Premysl ;
Vanner, Stephen .
GUT, 2017, 66 (07) :1241-1251
[3]
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin [J].
Lopetuso, Loris R. ;
Petito, Valentina ;
Scaldaferri, Franco ;
Gasbarrini, Antonio .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2016, 16 (03) :179-185
[4]
Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress [J].
Sundin, J. ;
Rangel, I. ;
Fuentes, S. ;
Heikamp-de Jong, I. ;
Hultgren-Hornquist, E. ;
de Vos, W. M. ;
Brummer, R. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (04) :342-351
[5]
Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)? [J].
Pinn, D. M. ;
Aroniadis, O. C. ;
Brandt, L. J. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2015, 27 (01) :19-29
[6]
Microbial endocrinology.[J].Mark Lyte.Gut Microbes.2014, 3
[7]
Rifaximin Alters Intestinal Bacteria and Prevents Stress-Induced Gut Inflammation and Visceral Hyperalgesia in Rats [J].
Xu, Dabo ;
Gao, Jun ;
Gillilland, Merritt, III ;
Wu, Xiaoyin ;
Song, Il ;
Kao, John Y. ;
Owyang, Chung .
GASTROENTEROLOGY, 2014, 146 (02) :484-+
[8]
Therapeutic faecal microbiota transplantation: current status and future developments [J].
Borody, Thomas J. ;
Brandt, Lawrence J. ;
Paramsothy, Sudarshan .
CURRENT OPINION IN GASTROENTEROLOGY, 2014, 30 (01) :97-105
[9]
Fecal excretion of Bifidobacterium infantis 35624 and changes in fecal microbiota after eight weeks of oral supplementation with encapsulated probiotic [J].
Charbonneau, Duane ;
Gibb, Roger D. ;
Quigley, Eamonn M. M. .
GUT MICROBES, 2013, 4 (03) :201-211
[10]
Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome [J].
Tana, C. ;
Umesaki, Y. ;
Imaoka, A. ;
Handa, T. ;
Kanazawa, M. ;
Fukudo, S. .
NEUROGASTROENTEROLOGY AND MOTILITY, 2010, 22 (05) :512-+